Heligenics

$6M disclosed across 3 rounds · 2020–2024

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

MA

Macrogenics Inc33 shared keywordsMacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer patients. It advances a pipeline of product candidates using proprietary platforms for antibody-drug conjugates, bispecific checkpoint antibodies, and T-cell engagers.

BI

Biogen Idec20 shared keywordsBiogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.

CE

Cenegenics17 shared keywordsCenegenics operates a personalized medicine program that measures over 100 biomarkers to establish a health baseline and delivers concierge physician care, diagnostics, and a data-driven plan focused on healthspan and human performance. It serves individuals seeking to improve longevity, metabolism, energy, cognition, and biological age.

Companies competing with Heligenics for the same Google search keywords, organic and paid, via search-intersection analysis.

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.